Education
About Us
Working with TipRanks
Follow Us
111, Inc. (YI)
:YI
YI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.14 - $11.90
Previous CloseN/A
Volume1.06M
Average Volume (3M)10.74K
Market Cap
$60.51M
Enterprise Value$162.94M
Total Cash (Recent Filing)$462.29M
Total Debt (Recent Filing)$256.77M
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding5,067,436
10 Day Avg. Volume16,197
30 Day Avg. Volume10,741
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.69
Enterprise Value/Revenue0.01
Enterprise Value/Gross Profit0.22
Enterprise Value/Ebitda21.30
Forecast
1Y Price Target
$7.00Price Target Upside0.00%
Rating ConsensusHold
Number of Analyst Covering0
111 News
YI FAQ
What was 111, Inc.’s price range in the past 12 months?
111, Inc. lowest stock price was $4.14 and its highest was $11.90 in the past 12 months.
What is 111, Inc.’s market cap?
111, Inc.’s market cap is $60.51M.
When is 111, Inc.’s upcoming earnings report date?
111, Inc.’s upcoming earnings report date is Aug 21, 2025 which is 7 days ago.
How were 111, Inc.’s earnings last quarter?
111, Inc. released its earnings results on Jun 19, 2025. The company reported -$0.279 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.279.
Is 111, Inc. overvalued?
According to Wall Street analysts 111, Inc.’s price is currently same.
Does 111, Inc. pay dividends?
111, Inc. does not currently pay dividends.
What is 111, Inc.’s EPS estimate?
111, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 111, Inc. have?
111, Inc. has 5,067,436 shares outstanding.
What happened to 111, Inc.’s price movement after its last earnings report?
111, Inc. reported an EPS of -$0.279 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.997%.
Which hedge fund is a major shareholder of 111, Inc.?
Currently, no hedge funds are holding shares in YI
111 Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.00 (0.00% )
$7.00 (0.00% )
Hedge Fund Trend
Decreased
By 90.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 15.0%
Last 30 Days ▼ 15.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.31%
12-Months-Change
Fundamentals
Return on Equity
40.55%
Trailing 12-Months
Asset Growth
-11.13%
Trailing 12-Months
Company Description
111, Inc.
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Technical Analysis
Ownership Overview
―
Insiders
0.05% Mutual Funds
0.31% Other Institutional Investors
99.64% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---